ADVISORY/blueprint WORLDWIDE INC Holds Press Conference to Unveil World's First Comprehensive Public Biomolecular Interaction Network Database to Accelerate Development of New Drugs.

News & Assignment Editors

ADVISORY...for Wednesday (May 30)

--(BUSINESS WIRE)

MDS Proteomics/blueprint

WHO:        Speakers:

            Mr. Francis Ouellette, Managing Director (Designate),
            blueprint
            Mr. Frank Gleeson, President and CEO, MDS Proteomics
            Dr. Caroline Kovac, Vice President, IBM Life Sciences
            Dr. Alan Bernstein, President, Canadian Institutes of
            Health Research (CIHR)

            Also in attendance will be representatives from the
            National Center for Biotechnology Information (NCBI), the
            Samuel Lunenfeld Research Institute (SLRI), the Institute
            of Genetics, the Institute of Cancer Research, and the
            Institute of Neurosciences, which are all part of the
            Canadian Institutes of Health Research (CIHR), and the
            Canadian Genetic Diseases Network (CGDN).

WHAT:       blueprint will unveil the world's first public
            comprehensive Biomolecular Interaction Network Database
            (BIND) available at www.blueprint.org. blueprint's BIND
            database enables researchers to easily find the quality
            data needed to speed the development of new medicines.

WHY:        Researchers need a standardized and centralized database
            to verify research results and derive insight from the
            global assembly of data. Currently, existing biomolecular
            data is presented in varying formats and is held in
            disparate locations.

WHERE:      The Chateau Laurier
            1 Rideau Street, Ottawa
            Via telephone conference at:
            US and Canada: [phone]
            International: [phone]

WHEN:       Wednesday, May 30, 2001, 12:30 p.m. EDT